Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Retsevmo

Retsevmo 40 mg hard capsules Retsevmo 80 mg hard capsules · Abschnitt 4.8 · PDF-Seite 16

HOS-146873 · Präparat HOS-099572

MedDRA system MedDRA preferred Frequency of all Frequency of Grade ≥ 3 organ class term Grades# Infections and infestations Urinary tract infectionsa Very common Common Pneumoniab Common Common Immune system disorders c Hypersensitivity d Very common Common Endocrine disorders Hypothyroidism e Very common - Metabolism and nutrition Decreased appetite Common - disorders Nervous system Headache Very common - disorders Dizziness Very common - Cardiac disorders Electrocardiogram QT Very common Common prolongedf Vascular disorders Haemorrhageg Very common - Hypertension Common Common Gastrointestinal Diarrhoeah Very common Common disorders Nausea Very common Common Abdominal pain i Very common - Vomiting Very common Common Constipation Very common Common Stomatitis Very common - Dry Mouth Common - Chylous ascites Common - Skin and subcutaneous Rashj Very common - tissue disorders Musculoskeletal and Musculoskeletal paink Very common - connective tissue disorders Epiphysiolysis of the Common Common femoral head Reproductive system and Erectile dysfunctionl Very common Common breast disorders General disorders and Pyrexia Very common - administration site Fatiguem Very common - conditions Oedeman Very common - Weight increased Very common Very common Investigationso Calcium decreased Very common Very common ALT increased Very common Common Albumin decreased Very common - AST increased Very common Common

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.